3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
11
Recruiting
4
Terminated
2
Active not recruiting
2
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Classical hematology
1
Conditions
Leukemia, Myeloid, Acute
5
Multiple Myeloma
3
Uveal Melanoma
2
Melanoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neuroblastoma
1
Neoplasms
1
Myelodysplastic Syndromes
1
Muscle Neoplasms
1
Leukemia, Plasma Cell
1
Chronic Pain
1
Breast Neoplasms
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
treosulfan
1
fludarabine
1
Melphalan
1
Honey
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Anemia, Refractory, with Excess of Blasts
×
Melphalan
×
Clear all
NCT07025824
2025-09-03
RELEVANT
Technische Universität Dresden
Phase 2
Not yet recruiting
220 enrolled